Last reviewed · How we verify
NCT05493306
Evaluation of Telerehabilitation Following Inpatient or Outpatient Rehabilitation Phase II
trial in Oncology in 126 participants. Completed in 30 June 2022.
31 March 2022
Quick facts
| Lead sponsor | Pensionsversicherungsanstalt |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 126 |
| Start date | 8 April 2021 |
| Primary completion | 31 March 2022 |
| Estimated completion | 30 June 2022 |
| Sites | 1 location across Austria |
Conditions studied
- Oncology — all drugs for Oncology →
- Musculoskeletal Diseases — all drugs for Musculoskeletal Diseases →
Sponsor
Pensionsversicherungsanstalt
Who can join
Eligibility, any sex, with Oncology or Musculoskeletal Diseases. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Telerehabilitation is implemented in the Pensionsversicherungsanstalt (PVA) as an independent rehabilitation offer following a rehabilitation phase II. This offer primarily includes physiotherapeutic training units in group settings and in individual counselling, as well as health-related educational sessions and doctor's consultations via video conferencing, initially for rehabilitation patients with diseases of the musculoskeletal system or oncological diseases. The first stage of the implementation process was evaluated with a focus on acceptance, usability and feasibility from the perspective of patients and treatment team. The evaluation was based on a convergent mixed methods design (Creswell \& Plano Clark, 2017) to draw on the strengths of qualitative and quantitative research approaches (Creswell \& Creswell, 2018). Qualitative and quantitative data were generated in parallel and treated equally. The perspective of the patients (N = 86) was collected through online questionnaires and in-depth telephone interviews (N = 22) and that of the treatment team through a questionnaire survey (N = 32) and focus group interviews (N = 24). The administrative team (N = 8) was asked for their assessment in a focus group interview. Technical difficulties in the implementation of telerehabilitation were documented by the treatment team. The consolidation of these multi-perspective results took place at the level of interpretation.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05493306
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Oncology
Currently open trials in the same condition.
- NCT07341464 — Acceptability and Tolerance Study of Bolus Tube Feed With Food Blends · NA · recruiting
- NCT07262632 — Developing a Multimodal Cancer Pain Database to Support AI-Based Automatic Pain Assessment · recruiting
- NCT06868524 — Leading Healthy Eating and Activity Promotion Program · NA · recruiting
- NCT06959810 — Impact of Adapted Aesthetic Onco in Patients With Upper Aerodigestive Tract Cancer During Their Management · NA · recruiting
- NCT06950073 — Curatively Intended Thoracic Reirradiation · recruiting
Other Pensionsversicherungsanstalt trials
Trials by the same sponsor.
- NCT06594120 — Changes in Workability and Employment Following the Work-related Medical Rehabilitation PV RehaJET · recruiting
- NCT06332859 — Effectiveness of a Resilience-Based Rehabilitation Program for Patients with Coronary Heart Disease · NA · recruiting
- NCT05500040 — Changes in Faecal Calprotectin Levels and Participation-related Scores Following Three Weeks of Inpatient Rehabilitation · completed
- NCT05480709 — Evaluation of Immediate and Medium-term Health- and Work-related Effects Following Inpatient Psychocardiological Rehabil · completed
- NCT05494892 — Development of a Research Agenda for Rehabilitation Research · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05493306 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Pensionsversicherungsanstalt
- Last refreshed: 12 August 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05493306.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing